References
- Middleton E, Jr. Antiasthmatic drug therapy and calcium ions: A review of pathogenesis and role of calcium. J Pharm Sci 1980; 69: 243–251
- McFadden E R, Jr. Calcium channel blocking agents and asthma. Ann Intern Med 1981; 95: 232–233
- Triggle D J. Calcium, the control of smooth muscle function and bronchial hyperreactivity. Allergy 1983; 38: 1–9
- Patel K R. Calcium antagonists in exercise-induced asthma. Br Med J 1981; 282: 932–933
- Cerrina J, Denjean A, Alexandre G, Lockhart A, Duruox P. Inhibition of exercise induced asthma by a calcium antagonist nifedipine. Am Rev Respir Dis 1981; 123: 156–160
- Henderson A F, Heaton R W, Costello J F. Effect of nifedipine on bronchoconstriction induced by inhalation of cold air. Thorax 1983; 38: 512–515
- Williams D O, Barnes P J, Vickers H P, Rudolf M. Effect of nifedipine on bronchomotor tone and histamine reactivity in bronchial asthma. Br Med J 1981; 283: 348
- Gonzales J M, Morice R C, Bloom K, et al. Inhibition of airway reactivity by nifedipine in coronary artery disease. Am Rev Respir Dis 1983; 127: 155–157
- Russi E W, Ahmed T. Calcium and calcium antagonists in airway disease. Chest 1984; 80: 1984
- Iseri L T, French J H. Magnesium: Nature's physiologic calcium blocker. Am Heart J 1984; 108: 188–193
- Okayama H, Aikawa T, Okayama M, et al. Bronchodilating effect of intravenous magnesium sulphate in bronchial asthma. JAMA 1987; 257: 1076–1078
- Rolla G, Bucca C, Bugiana M, et al. Reduction of histamine induced bronchoconstriction by magnesium in asthmatic subjects. Allergy 1987; 42: 186–188
- Hagiwara S. Calcium channel. Annu Rev Neurosci 1981; 4: 69–125
- Mayer M L, Westbrook G L, Guthrie P B, et al. Voltage dependent block by Mg2+ of NMDA responses. Nature 1984; 309: 261–263
- Meissner G, Henderson J S. Rapid calcium release from cardiac sarcoplasmic reticulum is dependent on calcium and is modulated by Mg2+ adenine nucleotide and calmodulin. J Biol Chem 1987; 262(7)3065–3073
- Snider G L. Staging therapy to the severity of asthma. Bronchial Asthma: Mechanisms and Therapeutics2nd ed., E B Weiss, M S Segal, M Stein. Little Brown, Boston 1985
- Sharma S K, Pande J N. Effect of verapamil inhalation on bronchial asthma. J Asthma 1990; 27: 31–36
- Rolla G, Bucca C, Caria E, et al. Acute effect of intravenous magnesium sulphate on airway obstruction of asthmatics. Ann Allergy 1988; 61: 388–391
- Skobeloff E M, Spivey W H, McNamara R M, Greenspon L. Intravenous magnesium sulphate for the treatment of asthma in the emergency department. JAMA 1989; 262: 1210–1213
- Noppen M, Vanmaele L, Impens N, Schandevyl W. Bronchodilaring effect of intraveneous magnesium sulphate in acute severe bronchial asthma. Chest 1990; 97: 373–376
- Haury V G. Blood serum magnesium in bronchial asthma, and its treatment by administration of magnesium sulphate. J Lab Clin Med 1940; 26: 340–341
- Rosello H J, Pla J C. Sulfato de magnesia en la crisis de asma. Pren Med Argen 1936; 23: 1677–1680
- Piper P, Vane J R. The release of prostaglandins from lung and other tissues. Ann NY Acad Sci 1971; 180: 363–385
- Wilson A F, Fairshter R D. Methods of assessing bronchoreversibility. Site of airway obstructing and bronchodilator response. Bronchial asthma: Mechanisms and Therapeutics2nd ed., E B Weiss, M Stein. Little Brown, Boston 1985; 319
- Molloy D W, Dhingra S, Solven S, Wilson A, McCarthy D S. Hypomagnesemia and respiratory muscle power. Am Rev Respir Dis 1984; 229: 497–498